|
Doreen Waldron Lechner, PhD
Senior Vice President, Quality Standards
Doreen joined Sentrx in 1999 as a Team Leader in Pharmacovigilance Operations. As the Company’s client base grew, so did Doreen’s responsibilities, and she was named Director of Operations in 2002. In July 2003, she was promoted to Executive Director of Quality Standards and has built a strong team with responsibility for quality assurance, training and regulatory compliance. She was named a Vice President in 2004.
Dr. Lechner began her career in the pharmaceutical industry at Wyeth-Ayerst in pre-clinical drug metabolism. She moved to Schering-Plough Corporation’s drug safety group and then into Regulatory Affairs as a Universal Regulatory Affairs Manager. Doreen then accepted a position at Bristol-Myers Squibb as Associate Director of Regulatory Affairs. In these positions Doreen was exposed to a variety of regulatory challenges including comprehensive management of FDA submissions, identification of safety issues, development of safety programs for Rx to OTC switches, and preparations for advisory committee meetings.
Dr. Lechner received her PhD in Pharmacology from the School of Biomedical Sciences at The University of Medicine and Dentistry of New Jersey. |
